Neuro-Oncology: The Podcast

99 Episodes

1. Targeted therapy for BRAF-mutant pediatric glioma

   Published: 17/06/2022
2. Early/evolving IDH wild-type glioblastoma

   Published: 20/05/2022
3. PI3K signaling in IDH mutant gliomas

   Published: 06/05/2022
4. Cell-free DNA from CSF in pediatric, adolescent and young adult patients

   Published: 22/04/2022
5. Molecular determinants of neurocognitive deficits in glioma

   Published: 08/04/2022
6. H3K27M cell-free tumor DNA tracking in response to ONC201 treatment for diffuse midline glioma

   Published: 25/03/2022
7. Clinical trial accrual for women and minorities in neuro-oncology

   Published: 11/03/2022
8. The clinical utility of next generation sequencing for IDHwt glioblastoma

   Published: 11/02/2022
9. Trabectedin for recurrent grade 2 or 3 meningiomas

   Published: 28/01/2022
10. Glioblastoma cell heterogeneity and plasticity

    Published: 14/01/2022
11. Moleculary integrated grading for meningioma

    Published: 24/12/2021
12. BOLD fMRI in IDH mutant gliomas

    Published: 10/12/2021
13. Glioblastoma subtypes and response to Dasatinib

    Published: 26/11/2021
14. Resection for recurrent brain metastases

    Published: 12/11/2021
15. Incidental Meningiomas

    Published: 29/10/2021
16. Immunosuppression in IDH mutant gliomas

    Published: 15/10/2021
17. Immunotherapy for melanoma brain metastases

    Published: 01/10/2021
18. DNA methylation profiles within the CATNON trial

    Published: 17/09/2021
19. 18F FET PET in childhood CNS tumors

    Published: 03/09/2021
20. Checkpoint blockade in atypical meningiomas

    Published: 20/08/2021